JP2022530442A5 - - Google Patents
Info
- Publication number
- JP2022530442A5 JP2022530442A5 JP2021563165A JP2021563165A JP2022530442A5 JP 2022530442 A5 JP2022530442 A5 JP 2022530442A5 JP 2021563165 A JP2021563165 A JP 2021563165A JP 2021563165 A JP2021563165 A JP 2021563165A JP 2022530442 A5 JP2022530442 A5 JP 2022530442A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- amino acid
- seq
- adc
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962838267P | 2019-04-24 | 2019-04-24 | |
| US62/838,267 | 2019-04-24 | ||
| PCT/US2020/029656 WO2020219774A1 (en) | 2019-04-24 | 2020-04-23 | Anthracycline antibody-drug conjugates and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022530442A JP2022530442A (ja) | 2022-06-29 |
| JP2022530442A5 true JP2022530442A5 (cg-RX-API-DMAC7.html) | 2023-05-01 |
Family
ID=72940981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563165A Withdrawn JP2022530442A (ja) | 2019-04-24 | 2020-04-23 | アントラサイクリン抗体薬物複合体およびその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220226493A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3959242A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022530442A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020219774A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10882915B2 (en) | 2017-10-24 | 2021-01-05 | Magenta Therapeutics, Inc. | Compositions and methods for the depletion of CD117+ cells |
| WO2019217942A1 (en) | 2018-05-11 | 2019-11-14 | Beam Therapeutics Inc. | Methods of substituting pathogenic amino acids using programmable base editor systems |
| CN113330026A (zh) * | 2018-10-23 | 2021-08-31 | 美真达治疗公司 | Fc沉默的抗体药物缀合物(ADC)及其用途 |
| CN120399078B (zh) * | 2025-05-08 | 2026-03-06 | 上海天泽云泰生物医药股份有限公司 | 靶向cd117的纳米抗体及其应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7214786B2 (en) * | 2000-12-14 | 2007-05-08 | Kovalic David K | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| AU2004260884B2 (en) * | 2003-07-22 | 2009-11-19 | Crucell Holland B.V. | Binding molecules against SARS-coronavirus and uses thereof |
| WO2009126730A2 (en) * | 2008-04-09 | 2009-10-15 | The Trustees Of The University Of Pennsylvania | Canine single chain fragment variable antibody libraries and uses thereof |
| US9221902B2 (en) * | 2008-11-07 | 2015-12-29 | Fabrus, Inc. | Combinatorial antibody libraries and uses thereof |
| AR086044A1 (es) * | 2011-05-12 | 2013-11-13 | Imclone Llc | Anticuerpos que se unen especificamente a un dominio extracelular de c-kit y usos de los mismos |
| EP3218400A1 (en) * | 2014-11-10 | 2017-09-20 | F. Hoffmann-La Roche AG | Anti-pdgf-b antibodies and methods of use |
| HK1256681A1 (zh) * | 2015-04-06 | 2019-10-04 | President And Fellows Of Harvard College | 用於非清髓性预处理的组合物和方法 |
| AU2016332900C1 (en) * | 2015-09-29 | 2024-07-04 | Amgen Inc. | ASGR inhibitors |
| KR20190014525A (ko) * | 2016-05-27 | 2019-02-12 | 애브비 바이오테라퓨틱스 인크. | 면역 조절 단백질과 종양 항원을 결합하는 이중특이적 결합 단백질 |
| US10111966B2 (en) * | 2016-06-17 | 2018-10-30 | Magenta Therapeutics, Inc. | Methods for the depletion of CD117+ cells |
| US10882915B2 (en) * | 2017-10-24 | 2021-01-05 | Magenta Therapeutics, Inc. | Compositions and methods for the depletion of CD117+ cells |
| WO2019084067A1 (en) * | 2017-10-24 | 2019-05-02 | Magenta Therapeutics, Inc. | ANTI-CD117 ANTIBODIES AND METHODS OF USE |
| WO2019084053A1 (en) * | 2017-10-24 | 2019-05-02 | Magenta Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR DEPLOYING CD117 + CELLS |
| EP3700568A4 (en) * | 2017-10-24 | 2021-11-10 | Magenta Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR DEPLOYING CD117 + CELLS |
| JP2021526525A (ja) * | 2018-06-07 | 2021-10-07 | マジェンタ セラピューティクス インコーポレイテッドMagenta Therapeutics, Inc. | 抗体薬物コンジュゲート(adcs)を用いた治療方法 |
| CN113330026A (zh) * | 2018-10-23 | 2021-08-31 | 美真达治疗公司 | Fc沉默的抗体药物缀合物(ADC)及其用途 |
| AU2019374055B2 (en) * | 2018-10-30 | 2026-06-11 | Regeneron Pharmaceuticals, Inc. | Methods for allogeneic hematopoietic stem cell transplantation |
| JP2022530438A (ja) * | 2019-04-24 | 2022-06-29 | マジェンタ セラピューティクス インコーポレイテッド | 抗cd117抗体薬物複合体およびその使用 |
| WO2020219778A2 (en) * | 2019-04-24 | 2020-10-29 | Magenta Therapeutics, Inc. | Anti-cd117 antibody-drug conjugates and uses thereof |
| CA3134319A1 (en) * | 2019-04-24 | 2020-10-29 | Rahul Palchaudhuri | Anti-cd117 antibodies and uses thereof |
-
2020
- 2020-04-23 JP JP2021563165A patent/JP2022530442A/ja not_active Withdrawn
- 2020-04-23 WO PCT/US2020/029656 patent/WO2020219774A1/en not_active Ceased
- 2020-04-23 EP EP20794532.0A patent/EP3959242A4/en not_active Withdrawn
-
2021
- 2021-10-21 US US17/507,531 patent/US20220226493A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022530438A5 (cg-RX-API-DMAC7.html) | ||
| EP4494657A1 (en) | Exatecan derivative-antibody conjugate and medical use thereof | |
| JP2022512778A5 (cg-RX-API-DMAC7.html) | ||
| WO2022078260A1 (zh) | 一种喜树碱类衍生物及其配体-药物偶联物 | |
| US12311030B2 (en) | Antibody-sting agonist conjugates and their use in immunotherapy | |
| JP5314590B2 (ja) | カンプトテシン結合部分 | |
| ES2795818T3 (es) | Anticuerpos CD48 y conjugados de los mismos | |
| KR20200017391A (ko) | 친수성 링커 및 이의 접합체 | |
| JP2022530089A5 (cg-RX-API-DMAC7.html) | ||
| ES2307294T3 (es) | Anticuerpos monoclonales de raton humanizados anti-cea tipo iii con injertados a cdr. | |
| RU2004135101A (ru) | Коньюгаты "производные калихеамицина-носитель" | |
| WO2019170131A1 (zh) | 靶向cd73的抗体及抗体-药物偶联物、其制备方法和用途 | |
| EP3335734A1 (en) | Linker-drug and antibody-drug conjugate (adc) employing the same | |
| IE76467B1 (en) | New linker for bioactive agents | |
| JP2009506790A (ja) | 毒素とコンジュゲートしたeph受容体抗体 | |
| JP2000503639A (ja) | 分枝ヒドラゾンのリンカー類 | |
| CN107074879A (zh) | 应用于细胞结合分子‑药物共轭体的新型细胞毒性分子 | |
| JP2025518739A (ja) | オリゴ糖リンカー、オリゴ糖リンカーを含むリンカー-ペイロード、および糖鎖がリモデリングされた抗体薬物複合体、その製造方法と使用 | |
| JP2023159335A5 (cg-RX-API-DMAC7.html) | ||
| EP3165237A1 (en) | Antibody-drug conjugate (adc) and method for forming the same | |
| TW202241454A (zh) | 抗體-免疫賦活化劑共軛物之新穎製造方法 | |
| TWI905962B (zh) | 用於綴合之化合物、綴合物及包含其之醫藥組成物 | |
| CN120417932A (zh) | 接头-有效载荷化合物、偶联物及其应用 | |
| EP4442283A1 (en) | Anti-human trop2 antibody-camptothecin drug conjugate and medical use thereof | |
| KR20230127918A (ko) | 신규 항체 약물 접합체 |